13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q2 2024 · Filed August 7, 2024 · Accession 0001754960-24-000403
Total Value
$140.1M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 46436E718 | 270,000 | $27.2M | 19.40% |
| 2 | ATEA PHARMACEUTICALS INC | AVIR | 6,375,621 | $21.1M | 15.06% |
| 3 | SPDR SER TR | 78468R663 | 200,000 | $18.4M | 13.10% |
| 4 | ACLARIS THERAPEUTICS INC | ACRS | 12,988,134 | $14.3M | 10.20% |
| 5 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,966,000 | $13.5M | 9.62% |
| 6 | TECTONIC THERAPEUTIC INC | TECX | 466,047 | $7.7M | 5.48% |
| 7 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,672,194 | $4.0M | 2.88% |
| 8 | INSTIL BIO INC | TIL | 391,103 | $4.0M | 2.87% |
| 9 | WINGSTOP INC | WING | 714 | $3.6M | 2.56% |
| 10 | ORAMED PHARMACEUTICALS INC | ORMP | 1,349,038 | $3.5M | 2.47% |
| 11 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 2,043,248 | $3.1M | 2.22% |
| 12 | ATHIRA PHARMA INC | 04746L104 | 900,000 | $2.4M | 1.70% |
| 13 | VANDA PHARMACEUTICALS INC | VNDA | 398,280 | $2.3M | 1.61% |
| 14 | PMV PHARMACEUTICALS INC | PMVP | 1,309,397 | $2.1M | 1.51% |
| 15 | ASTROTECH CORP | ASTC | 220,410 | $2.0M | 1.40% |
| 16 | MILESTONE PHARMACEUTICALS IN | MIST | 1,102,895 | $1.5M | 1.04% |
| 17 | DESIGN THERAPEUTICS INC | DSGN | 421,749 | $1.4M | 1.01% |
| 18 | VERRICA PHARMACEUTICALS INC | VRCA | 180,000 | $1.3M | 0.94% |
| 19 | LENZ THERAPEUTICS INC | LENZ | 63,916 | $1.1M | 0.79% |
| 20 | LISATA THERAPEUTICS INC | LSTA | 284,669 | $987,801 | 0.70% |
| 21 | IKENA ONCOLOGY INC | 45175G108 | 585,114 | $965,438 | 0.69% |
| 22 | FORTE BIOSCIENCES INC | FBRX | 1,761,702 | $946,034 | 0.68% |
| 23 | CALCIMEDICA INC | CALC | 160,424 | $635,279 | 0.45% |
| 24 | VISTAGEN THERAPEUTICS INC | VTGN | 150,000 | $522,000 | 0.37% |
| 25 | ACHILLES THERAPEUTICS PLC | 00449L102 | 625,174 | $509,517 | 0.36% |
| 26 | NEXTCURE INC | NXTC | 276,465 | $439,579 | 0.31% |
| 27 | ALLOVIR INC | 019818103 | 603,086 | $436,212 | 0.31% |
| 28 | TALIS BIOMEDICAL CORP | 87424L207 | 42,743 | $370,231 | 0.26% |